Brought to you by:
LINC 2021: Long-term data show sustained efficacy and safety of paclitaxel devices in fempop lesions
A key theme among the late-breaking trial data presented at the recent LINC 2021 (the Leipzig Interventional Course), held digitally from Jan. 25–29, was the emergence of long-term evidence on paclitaxel devices in the femoropopliteal segment. Results out to five years shows…
Upper-extremity vascular injuries associated with ‘increased prevalence’ of nerve deficits
Vascular injuries of the upper extremity are associated with a lower rate of limb loss but have an increased prevalence of nerve deficits after trauma, a new analysis comparing vascular trauma of the extremities reveals. The investigators behind the study—delivered…
Reimbursement
Reimbursement
Fempop atherectomy: Are high reimbursement amounts incentivizing inappropriate medical provider care?
Reimbursement-per-procedure for femoropopliteal atherectomy and stenting has increased at about the same rate for national providers as a whole and vascular surgeons specifically—at the same time as much higher rates were recorded for radiologists and general surgeons, an analysis of…
Journal supplement outlines updated clinical practice guidelines, reporting standards
The Society for Vascular Surgery (SVS) is starting 2021 with updated clinical practice guidelines and reporting standards for three vascular conditions. Guidelines on chronic mesenteric ischemia have been developed to provide the best possible evidence for the diagnosis and treatment…
System outage alert: Cyberattack sends medicine back to paper age
On Oct. 28, 2020, the University of Vermont Health Network—consisting of six hospitals in Vermont and upstate New York, was hit by a cyberattack.1 Leading up to the attack—the U.S. Cybersecurity and Infrastructure Security Agency (CISA) released a warning regarding ransomware…
Resident Research Award deadline moved to Feb. 17
The deadline for the Society for Vascular Surgery (SVS) Resident Research Award has been extended to Feb. 17—a knock-on effect of the date shift for the Vascular Annual Meeting (VAM). The SVS Basic and Translational Research Committee selects one recipient…
Deadlines near for Society, Foundation awards
Applications are due early in 2021 for a number of Society for Vascular Surgery (SVS) and SVS Foundation awards, honors and grants. Information on all awards and scholarships is available at vsweb.org January: Applications are due Jan. 13 for the…
Outpatient evaluation and management codes extensively revised
For the first time since 1992, office/outpatient evaluation and management (E/M) Current Procedural Terminology (CPT) codes have been extensively revised. As of Jan. 1, the lowest level new patient visit code 99201 will be deleted, and the remaining new patient…
Vesper Medical announces first enrollment in the VIVID trial
Vesper Medical recently announced initiation of its Food and Drug Administration (FDA) investigational device exemption (IDE) study, VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent system). The VIVID trial is a prospective, multicenter, single-arm study to…